Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Short Interest Update

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 2,400 shares, an increase of 20.0% from the December 15th total of 2,000 shares. Based on an average daily trading volume, of 15,700 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Trading of Tema Cardiovascular and Metabolics ETF

An institutional investor recently raised its position in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. lifted its position in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 3.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 158,695 shares of the company’s stock after acquiring an additional 5,605 shares during the quarter. Tema Cardiovascular and Metabolics ETF accounts for about 1.4% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 23rd biggest position. Sterling Investment Advisors Ltd. owned about 6.40% of Tema Cardiovascular and Metabolics ETF worth $5,332,000 at the end of the most recent reporting period.

Tema Cardiovascular and Metabolics ETF Price Performance

Shares of NASDAQ:HRTS traded down $0.19 during trading on Friday, reaching $28.70. The company had a trading volume of 10,235 shares, compared to its average volume of 12,749. Tema Cardiovascular and Metabolics ETF has a fifty-two week low of $28.56 and a fifty-two week high of $36.03. The stock’s fifty day moving average price is $30.62 and its 200 day moving average price is $32.85. The firm has a market capitalization of $66.30 million, a price-to-earnings ratio of 32.89 and a beta of 0.93.

Tema Cardiovascular and Metabolics ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were paid a $0.4693 dividend. The ex-dividend date was Wednesday, December 11th.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.